<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00545805</url>
  </required_header>
  <id_info>
    <org_study_id>LIMED0001</org_study_id>
    <secondary_id>FAPESP 05/58627-2</secondary_id>
    <nct_id>NCT00545805</nct_id>
  </id_info>
  <brief_title>Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric Surgery: Effects on Insulin Sensitivity</brief_title>
  <official_title>Effects of the Surgical Removal of Visceral Fat Tissue (Omentectomy) on Insulin Sensitivity in Grade III Obese Volunteers Subjected to Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Campinas, Brazil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Campinas, Brazil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intraabdominal fat is associated with insulin resistance, a condition that is in the
      basis of diabetes, metabolic syndrome and some cardiovascular diseases. It is not clear
      whether it is the origin of it or a surrogate marker only. We intend to compare the effects
      of bariatric surgery with versus without omentectomy in morbidly obese people intended to go
      through bariatric surgery, accessing insulin sensitivity by metabolic tests.

      If the visceral fat is causative of insulin resistance, its surgical removal (omentectomy)
      might lead to improvement of insulin action, as seen in animal studies and in one study with
      morbidly obese human volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to verify a potential additional benefit of omentectomy combined to Roux-en-Y
      silastic ring gastric bypass, insulin sensitivity will be studied by the gold-standard test,
      euglycemic-hyperinsulinemic clamp, since early postoperative follow-up (before significant
      weight variation), compared to a control group of bariatric surgery (same technique) alone.
      The variables will be analyzed in the post surgical evolution for correlation to metabolic
      changes: adiposity-related hormones and cytokines; lipid profile and other cardiovascular
      risk factors; molecular expression of biopsied subcutaneous adipocytes in vitro;
      anthropometrics; ultrasonography of abdominal subcutaneous and intra-abdominal fat depots and
      carotid intima-media thickness (preclinical atherosclerosis evaluation).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase of insulin sensitivity as measured by euglycemic-hyperinsulinemic clamp.</measure>
    <time_frame>one month, six months and one year.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>increase of insulin secretion as measured by intravenous glucose tolerance test</measure>
    <time_frame>one month, six months, one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>regression of carotid intima-media thickness</measure>
    <time_frame>one month, six months, one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of the insulin cell signalling in the subcutaneous adipose tissue.</measure>
    <time_frame>one month, six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>increase of adipocytokines linked to greater insulin sensitivity and decrease of others linked to insulin resistance</measure>
    <time_frame>one month, six months, one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Insulin Resistance</condition>
  <condition>Obesity</condition>
  <condition>Metabolic Syndrome X</condition>
  <arm_group>
    <arm_group_label>OM group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CT group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Roux-en-Y Gastric Bypass plus total omentectomy</intervention_name>
    <description>Roux-en-Y Gastric Bypass plus total omentectomy</description>
    <arm_group_label>OM group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Roux-en-Y Gastric Bypass</intervention_name>
    <description>Roux-en-Y Gastric Bypass without omentectomy</description>
    <arm_group_label>CT group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 21 and 50 years.

          -  Female sex.

          -  BMI between 40 and 50kg/m2.

          -  Metabolic syndrome (NCEP/ATP III criteria).

        Exclusion Criteria:

          -  Weight variation &gt;5% within 3 months prior to preoperative tests.

          -  Use of antidiabetic medications within 3 months prior to preoperative tests.

          -  HbA1c &gt;8%.

          -  Use of systemic corticosteroids for longer than 1 week within 3 months prior to
             preoperative tests.

          -  Hepatic cirrhosis, renal failure or any clinical condition (other than obesity)
             recognized as impairing insulin sensitivity.

          -  Present Smoking.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcelo MO Lima, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Campinas (UNICAMP)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bruno Geloneze, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Campinas (UNICAMP)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José Carlos Pareja, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Campinas (UNICAMP)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP)</name>
      <address>
        <city>Campinas</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Thörne A, Lönnqvist F, Apelman J, Hellers G, Arner P. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord. 2002 Feb;26(2):193-9.</citation>
    <PMID>11850750</PMID>
  </reference>
  <reference>
    <citation>Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J, Rossetti L. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes. 1999 Jan;48(1):94-8.</citation>
    <PMID>9892227</PMID>
  </reference>
  <reference>
    <citation>Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti L, Barzilai N. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes. 2002 Oct;51(10):2951-8.</citation>
    <PMID>12351432</PMID>
  </reference>
  <reference>
    <citation>Pitombo C, Araújo EP, De Souza CT, Pareja JC, Geloneze B, Velloso LA. Amelioration of diet-induced diabetes mellitus by removal of visceral fat. J Endocrinol. 2006 Dec;191(3):699-706.</citation>
    <PMID>17170226</PMID>
  </reference>
  <results_reference>
    <citation>Lima MM, Pareja JC, Alegre SM, Geloneze SR, Kahn SE, Astiarraga BD, Chaim EA, Geloneze B. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010 Aug;95(8):3871-5. doi: 10.1210/jc.2010-0085. Epub 2010 May 19.</citation>
    <PMID>20484482</PMID>
  </results_reference>
  <results_reference>
    <citation>Lima MM, Pareja JC, Alegre SM, Geloneze SR, Kahn SE, Astiarraga BD, Chaim ÉA, Baracat J, Geloneze B. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers. Obesity (Silver Spring). 2013 Mar;21(3):E182-9. doi: 10.1002/oby.20030.</citation>
    <PMID>23404948</PMID>
  </results_reference>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2007</study_first_submitted>
  <study_first_submitted_qc>October 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2007</study_first_posted>
  <last_update_submitted>February 17, 2013</last_update_submitted>
  <last_update_submitted_qc>February 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Campinas, Brazil</investigator_affiliation>
    <investigator_full_name>Marcelo Miranda de Oliveira Lima, MD, PhD</investigator_full_name>
    <investigator_title>Marcelo Miranda de Oliveira Lima, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Insulin resistance</keyword>
  <keyword>Metabolic syndrome X</keyword>
  <keyword>Obesity</keyword>
  <keyword>Intra-Abdominal Fat</keyword>
  <keyword>Omentum</keyword>
  <keyword>Bariatric surgery</keyword>
  <keyword>Glucose Clamp Technique</keyword>
  <keyword>Intravenous Glucose Tolerance Test</keyword>
  <keyword>Adiponectin</keyword>
  <keyword>Cytokines</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

